{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:34:22Z","timestamp":1767652462113,"version":"3.37.3"},"reference-count":20,"publisher":"The Journal of Rheumatology","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>The coronavirus disease 2019 (COVID-19) pandemic has created multiple uncertainties regarding rheumatic diseases or their treatment, with regard to the susceptibility to or severity of the viral disease. We aimed to address these questions as they relate to spondyloarthritis (SpA).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We created a longitudinal survey from April 10, 2020, to April 26, 2021. There were 4723 subjects with SpA and 450 household contacts who participated worldwide. Of these, 3064 respondents were from the US and 70.4% of them provided longitudinal data. To control for the duration of potential risk of COVID-19, the rate of contracting the disease was normalized for person-months of exposure.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In an analysis of US subjects who provided longitudinal data, the incident rate ratio for the 159 (out of 2157) subjects who tested positive for COVID-19 was 1.16 compared to the US population as adjusted for age and sex (range 0.997\u20131.361, <jats:italic>P<\/jats:italic> = 0.06). A paired evaluation using patients and household members did not show a statistically significant effect to indicate a predisposition for developing COVID-19 as a result of SpA or its treatment. Our data failed to show that any class of medication commonly used to treat SpA significantly affected the risk of developing COVID-19 or increasing the severity of COVID-19.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>These data do not exclude a small increased risk of developing COVID-19 as a result of SpA, but the risk, if it exists, is low and not consistently demonstrated. The data should provide reassurance to patients and to rheumatologists about the risk that COVID-19 poses to patients with SpA.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.210742","type":"journal-article","created":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T12:31:20Z","timestamp":1633091480000},"page":"225-229","source":"Crossref","is-referenced-by-count":12,"title":["The Interplay Between COVID-19 and Spondyloarthritis or Its Treatment"],"prefix":"10.3899","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8452-2441","authenticated-orcid":false,"given":"James T.","family":"Rosenbaum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5568-388X","authenticated-orcid":false,"given":"Michael H.","family":"Weisman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hedley","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cassie","family":"Shafer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elin","family":"Aslanyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard A.","family":"Howard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"Ogle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5950-0913","authenticated-orcid":false,"given":"John D.","family":"Reveille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3892-6947","authenticated-orcid":false,"given":"Kevin L.","family":"Winthrop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1552-4072","authenticated-orcid":false,"given":"Dongseok","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2262","published-online":{"date-parts":[[2021,10,1]]},"reference":[{"key":"2022062401251326000_49.2.225.1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217676"},{"key":"2022062401251326000_49.2.225.2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-020-05301-2"},{"key":"2022062401251326000_49.2.225.3","doi-asserted-by":"crossref","first-page":"e549","DOI":"10.1016\/S2665-9913(20)30169-7","article-title":"COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case-control study","volume":"2","author":"Fredi","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"2022062401251326000_49.2.225.4","doi-asserted-by":"crossref","first-page":"e557","DOI":"10.1016\/S2665-9913(20)30227-7","article-title":"COVID-19 in patients with rheumatic disease in Hubei province, China: a multicentre retrospective observational study","volume":"2","author":"Zhong","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"2022062401251326000_49.2.225.5","doi-asserted-by":"crossref","first-page":"102545","DOI":"10.1016\/j.jaut.2020.102545","article-title":"Prevalence of COVID infections in a population of rheumatic patients from Lombardy and Marche treated with biological drugs or small molecules: a multicentre retrospective study","volume":"116","author":"Sarzi-Puttini","year":"2021","journal-title":"J Autoimmun"},{"key":"2022062401251326000_49.2.225.6","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1002\/art.41456","article-title":"COVID-19 in patients with inflammatory arthritis: a prospective study on the effects of comorbidities and disease-modifying antirheumatic drugs on clinical outcomes","volume":"72","author":"Haberman","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2022062401251326000_49.2.225.7","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/art.41388","article-title":"Incidence of COVID-19 in patients with rheumatic diseases treated with targeted immunosuppressive drugs: what can we learn from observational data?","volume":"72","author":"Favalli","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2022062401251326000_49.2.225.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2009567"},{"key":"2022062401251326000_49.2.225.9","first-page":"85","article-title":"COVID-19 outcomes in patients with systemic autoimmune rheumatic diseases (SARDs) compared to the general population: a US multi-center comparative cohort study","volume":"383","author":"D\u2019Silva","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2022062401251326000_49.2.225.10","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1016\/S2665-9913(20)30422-7","article-title":"Temporal trends in severe COVID-19 outcomes in patients with rheumatic disease: a cohort study","volume":"3","author":"Jorge","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"2022062401251326000_49.2.225.11","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-219498"},{"key":"2022062401251326000_49.2.225.12","doi-asserted-by":"crossref","unstructured":"Kridin K , Schonmann Y , Solomon A , . Risk of COVID-19 infection, hospitalization, and mortality in patients with psoriasis treated by interleukin-17 inhibitors. J Dermatolog Treat 2021 March 24 (Epub ahead of print).","DOI":"10.1080\/09546634.2021.1905766"},{"key":"2022062401251326000_49.2.225.13","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-219564"},{"key":"2022062401251326000_49.2.225.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.09.009"},{"key":"2022062401251326000_49.2.225.15","first-page":"527","article-title":"Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients","volume":"80","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2022062401251326000_49.2.225.16","doi-asserted-by":"crossref","unstructured":"Cordtz R , Lindhardsen J , Soussi BG , . Incidence and severeness of COVID-19 hospitalisation in patients with inflammatory rheumatic disease: a nationwide cohort study from Denmark. Rheumatology 2020 Dec 28 (Epub ahead of print).","DOI":"10.1093\/rheumatology\/keaa897"},{"key":"2022062401251326000_49.2.225.17","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-eular.2431"},{"key":"2022062401251326000_49.2.225.18","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1038\/s41467-021-21903-z","article-title":"SARS-CoV-2 hijacks folate and one-carbon metabolism for viral replication","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat Commun"},{"key":"2022062401251326000_49.2.225.19","doi-asserted-by":"crossref","first-page":"198469","DOI":"10.1016\/j.virusres.2021.198469","article-title":"The folate antagonist methotexate diminishes replication of the coronavirus SARS-Cov-2 and enhances the antiviral efficacy of remdesivir in cell culture models","volume":"302","author":"Stegmann","year":"2021","journal-title":"Virus Res"},{"key":"2022062401251326000_49.2.225.20","doi-asserted-by":"crossref","unstructured":"Rosenbaum JT , Weisman MH , Shafer C , . Correspondence on \u2018Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry\u2019. Ann Rheum Dis 2021 May 13 (Epub ahead of print).","DOI":"10.1136\/annrheumdis-2021-220588"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.210742","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T08:26:31Z","timestamp":1656059191000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.210742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,1]]},"references-count":20,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2,1]]},"published-print":{"date-parts":[[2022,2]]}},"alternative-id":["10.3899\/jrheum.210742"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.210742","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"type":"print","value":"0315-162X"},{"type":"electronic","value":"1499-2752"}],"subject":[],"published":{"date-parts":[[2021,10,1]]}}}